Monophosphoryl Lipid A–based Adjuvant to Promote the Immunogenicity of Multivalent Meningococcal Polysaccharide Conjugate Vaccines

KR Alugupalli - ImmunoHorizons, 2024 - journals.aai.org
Activation of the adaptive immune system requires the engagement of costimulatory
pathways in addition to B and T cell Ag receptor signaling, and adjuvants play a central role …

Humoral and cellular immune responses induced by serogroup W135 meningococcal conjugate and polysaccharide vaccines

Y Cheng, R Shen, F Liu, Y Li, J Wang, Y Hou, Y Liu… - Vaccine, 2024 - Elsevier
Investigating the mechanisms by which W135 meningococcal conjugate (PSW135-TT)
activates adaptive immune responses in mice can provide a comprehensive understanding …

TLR4 ligands in typhoid Vi polysaccharide subunit vaccines contribute to immunogenicity

KR Alugupalli - Immunohorizons, 2024 - journals.aai.org
Activation of B cells and T cells requires the engagement of costimulatory signaling
pathways in addition to Ag receptor signaling for efficient immune responses. None of the …

The adjuvant effect of TLR7 agonist conjugated to a meningococcal serogroup C glycoconjugate vaccine

A Donadei, C Balocchi, F Mancini, D Proietti… - European Journal of …, 2016 - Elsevier
Conjugation of a small molecule immunopotentiator to antigens has been proposed to
deliver the ligand to the receptor, localize its action and minimize systemic inflammation …

A TLR4 ligand-based adjuvant for promoting the immunogenicity of Typhoid subunit vaccines

KR Alugupalli - Frontiers in Immunology, 2024 - frontiersin.org
None of the typhoid Vi Polysaccharide (ViPS) subunit vaccines incorporate adjuvants, and
the immunogenicity of ViPS vaccines (eg Typbar TCV® and Typhim Vi®) is in part due to …

Enhanced antibody responses to a detoxified lipopolysaccharide-group B meningococcal outer membrane protein vaccine are due to synergistic engagement of Toll …

WH Chen, S Basu, AK Bhattacharjee… - Innate …, 2010 - journals.sagepub.com
When given passively or elicited actively, antibodies induced by a detoxified Escherichia coli
Rc chemotype (J5) mutant lipopolysaccharide (J5dLPS)—group B meningococcal outer …

An adjuvant that increases protective antibody responses to polysaccharide antigens and enables recall responses

JP Phipps, KM Haas - The Journal of Infectious Diseases, 2019 - academic.oup.com
Protection against encapsulated bacteria can be elicited using polysaccharide vaccines.
These antigens often behave as T-cell–independent type 2 antigens (TI-2 Ags). However, TI …

Outer Membrane Protein Complex of Meningococcus Enhances the Antipolysaccharide Antibody Response to Pneumococcal Polysaccharide–CRM197 Conjugate …

Z Lai, JR Schreiber - Clinical and Vaccine Immunology, 2011 - Am Soc Microbiol
Bacterial polysaccharides (PS) are T cell-independent antigens that do not induce
immunologic memory and are poor immunogens in infants. Conjugate vaccines in which the …

Moderate PEGylation of the carrier protein improves the polysaccharide-specific immunogenicity of meningococcal group A polysaccharide conjugate vaccine

T Zhang, W Yu, Y Wang, T Hu - Vaccine, 2015 - Elsevier
Neisseria meningitidis can cause severe and fulminant diseases such as meningitis.
Meningococcal capsular polysaccharide (PS) is a key virulence determinant that is not able …

Preclinical development of the quadrivalent meningococcal (ACYW) tetanus toxoid conjugate vaccine, MenQuadfi®

R Kensinger, AB Arunachalam - Glycoconjugate Journal, 2022 - Springer
Bacterial capsular polysaccharide vaccines are generally poorly immunogenic in infants and
older adults. The immunogenicity of capsular polysaccharide vaccines can be improved by …